TELA Bio, Inc.
TELA
$1.15
$0.021.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.44% | 9.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.44% | 9.06% | |||
| Cost of Revenue | 10.47% | 1.42% | |||
| Gross Profit | -0.96% | 12.64% | |||
| SG&A Expenses | -8.62% | 2.64% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.54% | 0.99% | |||
| Operating Income | 16.82% | 13.28% | |||
| Income Before Tax | 13.01% | 11.79% | |||
| Income Tax Expenses | -- | -36.54% | |||
| Earnings from Continuing Operations | 13.30% | 11.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 13.30% | 11.91% | |||
| EBIT | 16.82% | 13.28% | |||
| EBITDA | 17.08% | 13.66% | |||
| EPS Basic | 13.40% | 12.10% | |||
| Normalized Basic EPS | 13.13% | 11.95% | |||
| EPS Diluted | 13.40% | 12.10% | |||
| Normalized Diluted EPS | 13.13% | 11.95% | |||
| Average Basic Shares Outstanding | 0.12% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||